Betmiga 50 mg


Prolonged-release tablet
scheduling status
S3
registration number
47/16.5/0298
What Betmiga 50 mg contains
mirabegron 50 mg.
other ingredients
Core tablet Macrogol 8,000 and 2,000,000 Hydroxypropylcellulose Butylhydroxytoluene Magnesium stearate Film coating: Hypromellose 2910, 6 mPa.s Macrogol 8,000 Iron oxide yellow (E172).
Therapeutic classification
G04BD.
© 2026 SAHPRA. ALL RIGHTS RESERVED